K. Fogh

919 total citations
32 papers, 728 citations indexed

About

K. Fogh is a scholar working on Immunology, Pharmacology and Dermatology. According to data from OpenAlex, K. Fogh has authored 32 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Pharmacology and 7 papers in Dermatology. Recurrent topics in K. Fogh's work include Psoriasis: Treatment and Pathogenesis (8 papers), Inflammatory mediators and NSAID effects (6 papers) and Asthma and respiratory diseases (6 papers). K. Fogh is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Inflammatory mediators and NSAID effects (6 papers) and Asthma and respiratory diseases (6 papers). K. Fogh collaborates with scholars based in Denmark, Germany and United States. K. Fogh's co-authors include Knud Kragballe, Troels Herlin, Lars Iversen, Anders Åström, John J. Voorhees, T. Ternowitz, H. Søgaard, Gustav Bojesen, J Kiil and Cody Bünger and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Archives of Biochemistry and Biophysics and Journal of Investigative Dermatology.

In The Last Decade

K. Fogh

32 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Fogh Denmark 15 239 226 211 142 115 32 728
N.J. Fincham United Kingdom 10 165 0.7× 167 0.7× 111 0.5× 84 0.6× 77 0.7× 18 503
AK Black Thailand 9 200 0.8× 96 0.4× 76 0.4× 48 0.3× 128 1.1× 14 558
Hanna Myśliwiec Poland 16 141 0.6× 273 1.2× 262 1.2× 145 1.0× 26 0.2× 50 707
Hani A. Al‐Shobaili Saudi Arabia 21 240 1.0× 247 1.1× 194 0.9× 92 0.6× 30 0.3× 44 830
Madeleine Rohac Austria 12 216 0.9× 55 0.2× 148 0.7× 154 1.1× 18 0.2× 14 778
Yoshiki Tsubosaka Japan 11 26 0.1× 221 1.0× 221 1.0× 117 0.8× 86 0.7× 14 717
Steven M. Morris United States 16 45 0.2× 99 0.4× 370 1.8× 146 1.0× 43 0.4× 26 855
Yo Kawakubo Japan 15 276 1.2× 227 1.0× 126 0.6× 95 0.7× 115 1.0× 33 703
A. Lupulescu United States 17 133 0.6× 57 0.3× 281 1.3× 54 0.4× 216 1.9× 69 962
Laure Favot France 18 88 0.4× 226 1.0× 381 1.8× 104 0.7× 57 0.5× 33 789

Countries citing papers authored by K. Fogh

Since Specialization
Citations

This map shows the geographic impact of K. Fogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Fogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Fogh more than expected).

Fields of papers citing papers by K. Fogh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Fogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Fogh. The network helps show where K. Fogh may publish in the future.

Co-authorship network of co-authors of K. Fogh

This figure shows the co-authorship network connecting the top 25 collaborators of K. Fogh. A scholar is included among the top collaborators of K. Fogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Fogh. K. Fogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogh, K., et al.. (2021). Pyoderma Gangrenosum: A Retrospective Study of Clinical Characteristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose. Acta Dermato Venereologica. 101(4). adv00431–adv00431. 10 indexed citations
2.
Tøttrup, Anders P., et al.. (2006). A Fatal Case of Malignant Atrophic Papulosis (Degos. Acta Dermato Venereologica. 86(3). 245–247. 14 indexed citations
3.
Fogh, K. & Knud Kragballe. (1997). Vitamin D3 analogues. Clinics in Dermatology. 15(5). 705–713. 18 indexed citations
4.
Fogh, K., et al.. (1996). All‐trans retinoic acid inhibits binding of 1,25‐dihydroxy‐vitamin D3 to the vitamin D receptor in cultured human keratinocytes. Experimental Dermatology. 5(1). 24–27. 5 indexed citations
5.
Sølvsten, Henrik, Mathias Tiedemann Svendsen, K. Fogh, & Knud Kragballe. (1994). The vitamin D receptor mRNA and protein is normal in psoriatic skin. Journal of Investigative Dermatology. 103(3). 409. 1 indexed citations
6.
Fogh, K., John J. Voorhees, & Anders Åström. (1993). Expression, Purification, and Binding Properties of Human Cellular Retinoic Acid-Binding Protein Type I and Type II. Archives of Biochemistry and Biophysics. 300(2). 751–755. 65 indexed citations
7.
Fogh, K., Lars Iversen, Troels Herlin, & Knud Kragballe. (1993). Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.. Acta Dermato Venereologica. 73(3). 191–193. 5 indexed citations
8.
Kragballe, Knud, K. Fogh, & H. Søgaard. (1991). Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.. Acta Dermato Venereologica. 71(6). 475–478. 47 indexed citations
9.
10.
Herlin, Troels, K. Fogh, Ebbe Stender Hansen, et al.. (1990). 15-HETE inhibits leukotriene B4 formation and synovial cell proliferation in experimental arthritis. Inflammation Research. 29(1-2). 52–53. 14 indexed citations
11.
Thorsen, Stine Buch, et al.. (1990). Leukotriene B4 in atopic dermatitis: increased skin levels and altered sensitivity of peripheral blood T‐cells. Allergy. 45(6). 457–463. 28 indexed citations
12.
Andreasen, Arne, Ebbe Stender Hansen, K. Fogh, Knud Kragballe, & Troels Herlin. (1990). Proliferation of adherent synovial fluid cell cultures is modified by eicosanoids. Apmis. 98(7-12). 605–608. 3 indexed citations
13.
Kragballe, Knud & K. Fogh. (1989). A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.. PubMed. 69(1). 23–8. 42 indexed citations
14.
Fogh, K., Troels Herlin, & Knud Kragballe. (1989). Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. Journal of Allergy and Clinical Immunology. 83(2). 450–455. 129 indexed citations
15.
Herlin, Troels, et al.. (1989). Effect of auranofin on eicosanoids and protein kinase C in human neutrophils. Inflammation Research. 28(1-2). 121–129. 8 indexed citations
16.
Fogh, K., Ebbe Stender Hansen, Troels Herlin, et al.. (1989). 15-Hydroxy-eicosatetraenoic acid (15-Hete) inhibits carragheenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). Prostaglandins. 37(2). 213–228. 45 indexed citations
17.
Fogh, K., Troels Herlin, & Knud Kragballe. (1988). In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils. Archives of Dermatological Research. 280(7). 430–436. 26 indexed citations
18.
Herlin, Troels, K. Fogh, Estrid Stæhr Hansen, et al.. (1988). Lipoxygenase products in experimental septic arthritis in dogs. Apmis. 96(7-12). 596–600. 1 indexed citations
19.
Herlin, Troels, K. Fogh, H. Ewald, et al.. (1988). Changes in lipoxygenase products from synovial fluid in carragheenan induced arthritis in dogs. Apmis. 96(7-12). 601–604. 19 indexed citations
20.
Herlin, Troels, et al.. (1987). CHEMOTACTIC LEUKOTRIENE B4 ACTIVITY IN PLASMA FROM CHILDREN WITH ARTHRITIS. Acta Pathologica Microbiologica Scandinavica Series C Immunology. 95C(1-6). 195–198. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N.J. Fincham Breakdown of academic impact, for papers by AK Black Breakdown of academic impact, for papers by Hanna Myśliwiec Breakdown of academic impact, for papers by Hani A. Al‐Shobaili Breakdown of academic impact, for papers by Madeleine Rohac Breakdown of academic impact, for papers by Yoshiki Tsubosaka Breakdown of academic impact, for papers by Steven M. Morris Breakdown of academic impact, for papers by Yo Kawakubo Breakdown of academic impact, for papers by A. Lupulescu Breakdown of academic impact, for papers by Laure Favot
Rankless by CCL
2026